Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1474835/000117184314000785/f20f_021814.htm
March 2019
March 2019
March 2019
February 2019
February 2019
February 2019
February 2019
January 2019
January 2019
December 2018
Please wait while we load the requested 20-F report or click the link below:
https://last10k.com/sec-filings/report/1474835/000117184314000785/f20f_021814.htm
Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Intellipharmaceutics International Inc..
Intellipharmaceutics International Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 20-F Annual Report
Material Contracts, Statements, Certifications & more
Intellipharmaceutics International Inc. provided additional information to their SEC Filing as exhibits
Ticker: IPCI
CIK: 1474835
Form Type: 20-F Annual Report
Accession Number: 0001171843-14-000785
Submitted to the SEC: Tue Feb 18 2014 7:00:47 AM EST
Accepted by the SEC: Tue Feb 18 2014
Period: Saturday, November 30, 2013
Industry: Pharmaceutical Preparations